Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after the drug led to significant weight loss in a mid-stage trial
Here are the top health stories for the day:Supreme Court Rejects Plea Seeking Reduced NEET Cutoff for BAMS Admissions 2025Denying a plea by Ayurvedic colleges seeking a reduction in the…
New Delhi: Padma Shri awardee Prof Dr Jagdev Singh Guleria, one of India’s most distinguished physicians, passed away on January 22 at the age of 98, marking the end of…
New Delhi: The Medical Counselling Committee (MCC) is scheduled to declare the NEET PG Round 3 counselling seat allotment result for the academic year 2025 on January 29, 2026, on…
Bhopal: In a shocking incident at the All India Institute of Medical Sciences (AIIMS) Bhopal, a woman employee was allegedly targeted in a chain snatching inside a lift on the…
Basti: In a recent judgment, the District Consumer Court has slapped Rs 9,10,000 compensation on the railways after a medical aspirant filed a case and claimed that she missed her…
In 2024, the USFDA issued a warning letter to Sun Pharma alleging "significant violations" of "current good manufacturing practice" regulations for pharmaceuticals made at the same production site in India.
Drug companies have announced a slew of deals for tools to unleash the promise of AI, seen as the biggest technological upheaval since the internet, much as other industries are…
Jaipur: In a recent crackdown, state authorities have de-empanelled eight hospitals and diagnostic centres from the Rajasthan Government Health Scheme (RGHS) last month over alleged irregularities, officials said on Saturday.…
Roche plans to launch pivotal studies of an experimental weight loss drug after a successful mid-stage trial.